Advisory Board President David Felsenthal Sells 6,437 Shares (ABCO)
Advisory Board (NASDAQ:ABCO) President David Felsenthal sold 6,437 shares of the stock on the open market in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $60.37, for a total value of $388,601.69. Following the sale, the president now directly owns 33,482 shares of the company’s stock, valued at approximately $2,021,308. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Advisory Board (NASDAQ:ABCO) traded up 1.81% during mid-day trading on Friday, hitting $62.88. 23,256 shares of the company’s stock traded hands. Advisory Board has a 52-week low of $42.72 and a 52-week high of $61.91. The stock has a 50-day moving average of $58.73 and a 200-day moving average of $54.42. The company has a market cap of $2.254 billion and a price-to-earnings ratio of 103.11.
Advisory Board (NASDAQ:ABCO) last announced its earnings results on Wednesday, July 31st. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.28 by $0.03. The company had revenue of $123.21 million for the quarter, compared to the consensus estimate of $121.88 million. During the same quarter in the prior year, the company posted $0.31 earnings per share. The company’s quarterly revenue was up 18.3% on a year-over-year basis. On average, analysts predict that Advisory Board will post $1.25 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Stephens initiated coverage on shares of Advisory Board in a research note to investors on Wednesday, October 2nd. They set an “overweight” rating on the stock. Separately, analysts at KeyCorp initiated coverage on shares of Advisory Board in a research note to investors on Monday, September 30th. They set a “buy” rating and a $72.00 price target on the stock. Finally, analysts at Merrill Lynch initiated coverage on shares of Advisory Board in a research note to investors on Friday, September 13th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Advisory Board presently has a consensus rating of “Buy” and a consensus price target of $64.00.
The Advisory Board Company provides best practices research and analysis, software tools, and management and advisory services to the health care and education industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.